BIO.News Newsletter

This week is off to a busy start, with the House introducing bills to strengthen the Vaccine Injury Compensation Program, Colorado’s PDAB taking action, and an important discussion on AMR and amputees. (834 words, 4 minutes, 10 seconds)

A busy news Friday: CDC advisors voted to recommend the routine use of the first approved monoclonal antibody for RSV in infants, and a new poll shows voters like agricultural biotech and want faster regulatory approvals. (528 words, 2 minutes, 38 seconds)

We have profiles of three cancer innovators—and why it matters in the context of recent policy developments. Plus, the Pantheon Awards are accepting nominations until August 11 and NIH announced Dr. Fauci’s successor. (476 words, 2 minutes, 22 seconds)

BIO recently submitted comments to the U.S. Senate on the 340B program—here’s what we said, plus a recap of a successful BIO Asia-Taiwan. (406 words, 2 minutes, 1 second)

Happy August. BIO’s Dr. Hans Sauer explains exactly who funds biotech R&D, and a tick-borne allergy is on the rise as temperatures change ticks’ habits. (653 words, 3 minutes, 15 seconds)

BIO Chair Dr. Ted W. Love has a must-read op-ed on how recent policy actions would have kept patients from accessing his breakthrough sickle cell treatment. Speaking of policy, the EU has proposed new compulsory licensing rules—we have BIO’s take. (550 words, 2 minutes, 45 seconds)

Ending the week with the role of biotech in national security and curing hepatitis, plus more reading and listening for this hot summer weekend. (521 words, 2 minutes, 36 seconds)

More activity on the Hill yesterday on PBMs—catch up below. And no, you’re not imagining that there are more mosquitoes—here’s why that’s a problem. (599 words, 2 minutes, 59 seconds)

The EU approved a framework to support data sharing with the U.S.—here’s what it means for research and collaboration. Plus, creative use of gene therapy gave a boy his sight back—but policy might discourage this kind of innovation. (490 words, 2 minutes, 27 seconds)

Today, we look at new technologies to develop new antimicrobials (and how to fix the market) and one researcher’s thoughts on the EU’s proposed reform of its CRISPR regulation—plus, Summer Science Splash returns with what voters think about pandemic preparedness. (720 words, 3 minutes, 36 seconds)